Insulin prices.

MOST pharmaceutical companies have been exploiting the masses by raising the prices of their products unilaterally and arbitrarily. It is a pity that the regulatory authorities concerned do little in the name of market regulation.

Diabetes is a life-long condition which needs life-long management. Type 1 diabetes is often diagnosed soon after birth. Such people need the administration of insulin injections across their lives. There is no substitute that may do the trick.

Till last year, the insulin that was available for Rs1,000 now costs Rs2,300. What are the pharmaceutical companies up to? Do they want diabetics to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT